Have a personal or library account? Click to login
The Contribution of Endothelial Marker Proteins in the Determination of Vascular Angiogenic Potential, in Normal Physiological Conditions and in Neoplasia Cover

The Contribution of Endothelial Marker Proteins in the Determination of Vascular Angiogenic Potential, in Normal Physiological Conditions and in Neoplasia

Medical Journal of Cell Biology
Volume 3 (2011): Issue 4 (November 2011)
By: Aneta Konwerska,  Beata Janik,  Agnieszka Malinska,  Wojciech Witkiewicz and  Maciej Zabel  
Open Access
|Oct 2014

References

  1. [1] BARAŃSKA P, JERCZYŃSKA H, PAWŁOWSKA Z. Czynnik wzrostu śródbłonka naczyń - budowa i funkcje. Postępy Biochem 2005; 51: 13-21.
    Search in Google Scholar
  2. [2] BECKER R, LENTER MC, VOLLKOMMER T, BOOS AM, PFAFF D, AUGUSTIN HG, CHRISTIAN S. Tumor stroma marker endosialin (Tem1) is a binding partner of metastasis - related protein Mac-2 BP/90K. FASEB J 2008; 22: 3059-67.10.1096/fj.07-10138618490383
    Search in Google Scholar
  3. [3] BERGRES G, BENJAMIN L. Tumorigenesis and the angiogenic switch. Net Rev Cancer 2003; 3 (6): 401-410.10.1038/nrc109312778130
    Search in Google Scholar
  4. [4] CAPETTINI LS, CORTES SF, GOMES MA, SILVA GA, PESQUERO JL, LOPES MJ, TEIXEIRA MM, LEMOS VS. Neuronal nitric oxide synthase-derived hydrogen peroxide is a major endothelium-dependent relaxing factor. Am J Physiol Heart Circ Physiol 2008; 295: H2503-H2511.10.1152/ajpheart.00731.200818952716
    Search in Google Scholar
  5. [5] CHAN YC, LEUNG FP, WONG WT, TIAN XY, YUNG LM, LAU CW, TSANG SY, YAO X, CHEN ZY, HUANG Y. Therapeutically relevant concentrations of raloxifene dilate pressurized rat resistance arteries via calcium-dependent endothelial nitric oxide synthase activation. Arterioscler Thromb Vasc Biol 2010; 30: 992-999.10.1161/ATVBAHA.110.20393520185791
    Search in Google Scholar
  6. [6] CHRISTIAN S, WINKLER R, HELFRICH I, Boos AM, BESEMFELDER E, SCHADENDORF D, AUGUSTIN HG. Endosialin (Tem1) is a marker of tumor-associated myofibroblasts and tumor vessel-associated mural cells. Am J Pathol 2008; 172: 486-94.10.2353/ajpath.2008.070623231237418187565
    Search in Google Scholar
  7. [7] CIERNIEWSKI CS. Regulacja angiogenezy - nowa broń onkologii. Biol Molek 2006; 1 (5): 20-22.
    Search in Google Scholar
  8. [8] DANESHTALAB N, SMEDA JS. Alterations in the modulation of cerebrovascular tone and blood flow by nitric oxide synthases in SHRsp with stroke. Cardiovasc Res 2010; 86: 160-168.10.1093/cvr/cvp39520008826
    Search in Google Scholar
  9. [9] DAVIES G, RMALI KA, WATKINS G, MANSEL RE, MASON MD, JIANG. Elevated levels of tumour endothelial marker-8 in human breast cancer and its clinical significance. Int J Oncol 2006; 29: 1311-7.10.3892/ijo.29.5.1311
    Search in Google Scholar
  10. [10] DEANFIELD JE, HALCOX JP, RABELINK TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007; 115 (10): 1285-1295.10.1161/CIRCULATIONAHA.106.65285917353456
    Search in Google Scholar
  11. [11] DENIS CV. Molecular and cellular biology of von Willebrand factor. Int J Hematol 2002; 75: 3-8.10.1007/BF0298197211843287
    Search in Google Scholar
  12. [12] DIAS FA, URBONIENE D, YUZHAKOVA MA. Ablation of iNOS delays cardiac contractile dysfunction in chronic hypertension. Front Biosci 2010; 2: 312-24.
    Search in Google Scholar
  13. [13] DIGNAT-GEORGE F, SAMPOL J. Circulation endothelial cells in vascular disordes: new insights into an old concept. Eur J Haematol 2000; 65: 215-220.10.1034/j.1600-0609.2000.065004215.x11073162
    Search in Google Scholar
  14. [14] FUCHS B, MAHLUM E, HALDER C. High expression of tumor endothelial marker 7 is associated with metastasis and poor survival of patients with osteogenic sarcoma. Gene 2007; 399: 137-43.10.1016/j.gene.2007.05.003206618517560052
    Search in Google Scholar
  15. [15] FÜRSTENBERGER G, VON MOOS R, LUCAS R, THÜRLIMANN B, SENN H, HAMACHER J, BOENEBERG EM: Circulating endothelial cells and angiogenic serum factors during neoadiuvant chemotherapy of primary breast cancer. Br J Cancer 2006; 94: 524-531.10.1038/sj.bjc.6602952236117116450002
    Search in Google Scholar
  16. [16] GOOK PK, LIP GY, BOOS CJ, STONELAKE PS, BLANN AD. Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer. Neoplasia 2006; 8 (2): 79-88.10.1593/neo.05592157851316611400
    Search in Google Scholar
  17. [17] HAI-FENG D, XIAN-WEN H, JIN-LONG C, LI-HUA G. Antitumor Activities of TEM8-Fc: An Engineered Antibody-like Molecule Targeting Tumor Endothelial Marker 8. J Natl Cancer Inst 2007; 99 (20): 1551-1555.10.1093/jnci/djm13217925540
    Search in Google Scholar
  18. [18] HALDER C, OSSENDORF C, MARAN A, YASZEMSKI M, BOLANDER ME, FUCHS B, SARKAR G. Preferential Expression of the Secreted and Membrane forms of Tumor Endothelial Marker 7 transcripts in Osteosarcoma. Anticancer Res 2009; N; 29 (11): 4317-4322.
    Search in Google Scholar
  19. [19] HRISTOV M, WEBER C. Endothelial progenitor cells: characterization, pathophysiology and possible clinical relevance. J Cell Mol Med 2004; 8 (4): 498-508.10.1111/j.1582-4934.2004.tb00474.x674028915601578
    Search in Google Scholar
  20. [20] KHNYTKIN D, TROEN G, BERNER JN. The expression of fibroblast growth factors and their receptors in Hodgkin’s lymphoma. J Pathol 2006; 208 (3): 431-438.10.1002/path.190016353171
    Search in Google Scholar
  21. [21] KLUZ J, ADAMIEC R. Krążące komórki śródbłonka w zapalnych chorobach naczyń. Adv Clin Exp Med 2007; 16 (1): 95-104.
    Search in Google Scholar
  22. [22] KRAUSE DS, FACKLER MJ, CIVIN CI, MAY WS. CD34: structure, biology, and clinical utility. Blood 1996 ; 1: 87 (1): 1-13.10.1182/blood.V87.1.1.bloodjournal8711
    Search in Google Scholar
  23. [23] LEE JH, PALAIA T, RAGOLIA L. Impaired insulin-mediated vasorelaxation in diabetic Goto- Kakizaki rats is caused by impaired Akt phosphorylation. Am J Physiol Cell Physiol 2009; 296: C327-38.10.1152/ajpcell.00254.2008264384819052261
    Search in Google Scholar
  24. [24] KOPCZYŃSKA E. Śródbłonkowe markery nowotworowe. Współczesna Onkologia 2008; 12, 6: 255-260.
    Search in Google Scholar
  25. [25] LEKONSTEVA O, CHAKRABARTI S, JIANG Y, CHEUNG CC, DAVIDGE ST. Role of Neuronal Nitric Oxide Synthase in Estrogen-Induced Relaxation in Rat Resistance Arteries. J Pharmacol Exp Ther 2011. JPET Fast Forward. Published on August 1, 2011 as DOI:10.1124/jpet.111.18379810.1124/jpet.111.18379821807885
    Search in Google Scholar
  26. [26] MELIKAN N, SEDDON MD, CASADEI B, CHOWIENCZYK PJ, SHAH AM. Neuronal nitric oxide synthase and human vascular regulation. Trends Cardiovasc Med 2009; 19: 256-262.10.1016/j.tcm.2010.02.007298461720447567
    Search in Google Scholar
  27. [27] MEREGALLI M, FARINI A, BELICCHI M, TORRENTE Y. CD133(+) cells isolated from various sources and their role in future clinical perspectives. Expert Opin Biol Ther 2010; 10 (11): 1521-8.10.1517/14712598.2010.52838620932225
    Search in Google Scholar
  28. [28] MIZIA-MALARZ M, SOBOL G, WOŚ H. Angiogeneza w przewlekłych schorzeniach zapalnych i nowotworowych. Pol Merkuriusz Lek 2008; XXIV, 141: 185-189.
    Search in Google Scholar
  29. [29] MOZAFFARIAN D, WILSON PW, KANNEL WB. Beyond established and novel risk factors: lifestyle risk factors for cardiovascular disease. Circulation 2008; 117 (23): 3031-3038.10.1161/CIRCULATIONAHA.107.73873218541753
    Search in Google Scholar
  30. [30] NAGAREDDY PR, SOLIMAN H, LIN G. Selective inhibition of protein kinase C beta(2) attenuates inducible nitric oxide synthase-mediated cardiovascular abnormalities in streptozotocin-induced diabetic rats. Diabetes 2009; 58: 2355-64.10.2337/db09-0432275021819587355
    Search in Google Scholar
  31. [31] NANDA A, KARIM B, PENG Z. Tumor endothelial marker 1 (TEM1) functions in the growth and progression of abdominal tumors. PNAS 2006; 103: 3351-6.10.1073/pnas.0511306103141393116492758
    Search in Google Scholar
  32. [32] NEWMAN PJ, ALBELDA SM. Cellular and molecular aspects of PECAM-1. Nouv Rev Fr Hematol 1992; 34 Suppl: S9-13.
    Search in Google Scholar
  33. [33] NICO B, BENAGIANO V, MANGIERI D, MARUOTTI N, VACCA A, RIBATTI D. Evaluation of microvascular density in tumors: pro and contra. Histol Histopathol 2008 May; 23 (5): 601-7.
    Search in Google Scholar
  34. [34] NOWICKI M, MISTERSKI M, MALINSKA A, PEREK B, OSTALSKA-NOWICKA D, JEMIELITY M, WITKIEWICZ W, ZABEL M. Endothelial integrity of radial artery grafts harvest by minimally invasive surgery - immunohistochemical studies of CD 31 and endothelial nitric oxide synthase expression: a randomized trial. Eur J Cardiothorac Surg 2011; 39: 471-477.10.1016/j.ejcts.2010.08.00520851617
    Search in Google Scholar
  35. [35] OWOC-LEMPACH J, CHYBICKA A. Znaczenie angiogenezy w nowotworach występujących w populacji dziecięcej. Onkol Pol 2006; 9 (3): 87-92.
    Search in Google Scholar
  36. [36] PADUCH R. Przerzut nowotworowy - znaczenie agregacji komórek nowotworowych z płytkami krwi. Onkol Pol 2005; 8, 4: 229-238.
    Search in Google Scholar
  37. [37] PAUTZ A, ART J, HAHN S. Regulation of the expression of inducible nitric oxide synthase. Nitric Oxide 2010; 23: 75-93.10.1016/j.niox.2010.04.00720438856
    Search in Google Scholar
  38. [38] PRIVRATSKY JR, PADDOCKCM, FLOREY O, NEWMAN DK, MULLER WA, NEWMAN PJ. Relative contribution of PECAM-1 adhesion and signaling to the maintenance of vascular integrity. J Cell Sci 2011; 124: 1477-85.10.1242/jcs.082271307881421486942
    Search in Google Scholar
  39. [39] RIBATTI D. The involvement of endothelial progenitor cells in tumor angiogenesis.: J Cell Mol Med, 2004; 8: 294-300.10.1111/j.1582-4934.2004.tb00319.x674014615491505
    Search in Google Scholar
  40. [40] RIBATTI D, MARIMPIETRI D, PASTORINO F, BRIGNOLE C, NICO B, VACCA A, PONZONI M. Angiogenesis in Neuroblastoma. Ann NY Acad Sci 2004; 1028: 133-142.10.1196/annals.1322.01415650239
    Search in Google Scholar
  41. [41] SAGRINATI C, NETTI GS, MAZZINGHI B, LAZZERI E, LIOTTA F, FROSALI F, RONCONI E, MEINI C, GACCI M, SQUECCO R, CARINI M, GESUALDO L, FRANCINI F, MAGGI E, ANNUNZIATO F, LASAGNI L, SERIO M, ROMAGNANI S, ROMAGNANI P. Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J Am Soc Nephrol 2006; 17 (9): 2443-56.10.1681/ASN.200601008916885410
    Search in Google Scholar
  42. [42] SEDDON M, MELIKIAN N, DWORAKOWSKI R, SHABEEH H, JIANG B, BYRNE J, CASADEI B, CHOWIENCZYK P, SHAH AM. Effects of neuronal nitric oxide synthase on human coronary artery diameter and blood flow in vivo. Circulation 2009; 119: 2656-2662.10.1161/CIRCULATIONAHA.108.82220519433760
    Search in Google Scholar
  43. [43] SIMONAVICIUS N, ROBERTSON D, BAX DA, JONES C, HUIJBERS IJ, ISACKE CM. Endosialin (CD248) is a marker of tumor-associated pericytes in high-grade glioma. Mod Pathol 2008; 21: 308-15.10.1038/modpathol.380100618192970
    Search in Google Scholar
  44. [44] SKÓRA J, BIEGUS J, PUPKA A, BARĆ P, SIKORA J, SZYBER P. Molekularne podstawy angiogenezy. Postępy Hig Med Dośw 2006; 60: 410-415.
    Search in Google Scholar
  45. [45] SOSKIĆ SS, DOBUTOVIC BD, SUDAR EM, OBRADOVIĆ MM, NIKOLIĆ DM, DJORDJEVIC JD, RADLAK DJ, MIKHAILIDIS DP, ISENOVIĆ ER. Regulation of Inducible Nitric Oxide Synthase (iNOS) and its Potential Role in Insulin Resistance, Diabetes and Heart Failure. Open Cardiovasc Med J 2011; 5: 153-163.10.2174/1874192401105010153314134421792376
    Search in Google Scholar
  46. [46] SUDAR E, DOBUTOVIC B, SOSKIE S. Regulation of inducible nitric oxide synthase activity/expression in rat hearts from ghrelin-treated rats. The Open Cardiovascular Medicine Journal 2011; 5: 153-163.
    Search in Google Scholar
  47. [47] SUGIURA T, DOHI Y, TAKASE H, YAMASHITA S, TANAKA S, KIMURA G. Increased reactive oxygen metabolites is associated with cardiovascular risk factors and vascular endothelial damage in middle-aged Japanese subjects. Vasc Health Risk Manag 2011; 7: 475-482.10.2147/VHRM.S23097314842121822395
    Search in Google Scholar
  48. [48] ŚWIDZIŃSKA E, NAUMNIK W, CHYCZEWSKA E. Angiogeneza i neoangiogeneza - znaczenie w raku płuca i innych nowotworach. Pneumonol Alergol Pol 2006; 74: 414-420.
    Search in Google Scholar
  49. [49] TOMKOWICZ B, RYBINSKI K, FOLEY B. Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration. PNAS 2007; 104: 17965-70.10.1073/pnas.0705647104208428017986615
    Search in Google Scholar
  50. [50] VALLON M, ESSLER M. Proteolytically processed soluble tumor endothelial marker (TEM) 5 mediates endothelial cell survival during angiogenesis by linking integrin alpha(v)beta3 to glycosaminoglycans. J Biochem 2006; 281 (45): 34179-88.
    Search in Google Scholar
  51. [51] VANHOUTTE PM, SHIMOKAWA H, TANG EH, FELETOU M. Endothelial dysfunction and vascular disease. Acta Physiol Hung 2009; 196 (2): 193-222.10.1111/j.1748-1716.2009.01964.x19220204
    Search in Google Scholar
  52. [52] WALSKI M, FRONTCZAK-BANIEWICZ M. Cechy ultrastrukturalne prawidłowego i dysfunkcyjnego śródbłonka naczyń krwionośnych. Pol Arch Med Wewn 2007; 117 (Supl.): 46-49.10.20452/pamw.270
    Search in Google Scholar
  53. [53] WERNER E, KOWALCZYK AP, FAUNDEZ V. Anthrax toxin receptor 1/tumor endothelium marker 8 mediates cell spreading by coupling extracellular ligands to the actin cytoskeleton. J Biol Chem 2006; 281: 23227-36.10.1074/jbc.M60367620016762926
    Search in Google Scholar
  54. [54] WHITE AR, RYOO S, LI D. Knockdown of arginase I restores NO signaling in the vasculature of old rats. Hypertension 2006; 47: 245-51.10.1161/01.HYP.0000198543.34502.d716380531
    Search in Google Scholar
  55. [55] WNUCZKO K, SZCZEPAŃSKI N. Śródbłonek-charakterystyka i funkcje. Pol Merkuriusz Lek 2007; XXIII, 133: 60-65.
    Search in Google Scholar
  56. [56] WOYWODT A, BAHLMANN F, DE GROOT K, HALLER H, HAUBITZ M. Circulation endothelial cells: life, death, detachment and repair of the endothelial cell layer. Nephrol Dial Transplant 2002; 17: 1728-1730.10.1093/ndt/17.10.172812270976
    Search in Google Scholar
  57. [57] WRÓBEL T, MAZUR G, DZIĘGIEL P. Density of intranodal lymphatics and VEGF-C expression in B-cell lymphoma and reactive lymph nodes. Folia Histochem Cytobiol 2006; 44: 43-47.
    Search in Google Scholar
  58. [58] WRÓBEL T., PORĘBA M., MAZUR G. Angiogenic and coagulation - fibrinolysis factors in non- Hodgkin’s lymphoma. Neoplasma 2006; 53: 253-258.
    Search in Google Scholar
  59. [59] YUAN J, OSSENDORF C, SZATKOWSKI JP, BRONK JT, MARAN A, YASZEMSKI M, BOLANDER ME, SARKAR G, FUCHS B. Osteoblastic and osteolytic human osteosarcomas can be studied with a new xenograft mouse model producing spontaneous metastases. Cancer Invest 2009; 27: 435-442.10.1080/07357900802491477272394419212826
    Search in Google Scholar
  60. [60] ZAKULA Z, KORICANAC G, PUTNIKOVIC B, MARKOVIC L, ISENOVIC ER. Regulation of the inducible nitric oxide synthase and sodium pump in type 1 diabetes. Med Hypotheses 2007; 69: 302-306.10.1016/j.mehy.2006.11.04517289286
    Search in Google Scholar
  61. [61] ZHANG P, XU X, HU X. Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure. Circ Res 2007; 100: 1089-98. 10.1161/01.RES.0000264081.78659.45238685717363700
    Search in Google Scholar
DOI: https://doi.org/10.2478/v10052-011-0005-2 | Journal eISSN: 2544-3577
Journal RSS Feed
Language: English
Page range: 69 - 83
Published on: Oct 15, 2014
Published by: Foundation for Cell Biology and Molecular Biology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
endothelium,
angiogenesis,
progenitor cells,
endothelial markers (CD31,
CD34,
CD133,
endothelial Nitric Oxide Synthase,
von Willebrand factor)
Related subjects:
Life sciences,
Molecular biology,
Biochemistry

© 2014 Aneta Konwerska, Beata Janik, Agnieszka Malinska, Wojciech Witkiewicz, Maciej Zabel, published by Foundation for Cell Biology and Molecular Biology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 3 (2011): Issue 4 (November 2011)